FDA Approves Groundbreaking New Product Utilizing Berkshire Sterile Excipient Gel to Treat ‘Butterfly Children’
Globe Newswire On May 19, 2023, Krystal Biotech, a client of Berkshire Sterile Manufacturing (BSM), received FDA approval for VYJUVEK™, the first-ever topical gene therapy approved to treat dystrophic epidermolysis…
Drug Product Filled with Berkshire Sterile’s Low Loss Fill Process Receives FDA Green Light
Globe Newswire RNAimmune, a biotech company focused on developing groundbreaking mRNA therapies, recently received FDA approval to begin Phase 1 clinical studies for an investigational new drug (IND). The drug…
Berkshire Sterile achieves its first commercial drug approval by the FDA
Lee, MA, Mar 22, 2022 (GLOBE NEWSWIRE) -- On March 1, 2022, a long-term client of Berkshire Sterile Manufacturing (BSM) announced the FDA approval of their Abbreviated New Drug Application…
